Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities von Brem, Elizabeth A., Sehn, Laurie H.

Volltext

Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd‐Generation Bruton Tyrosine Kinase Inhibitor‐Based Therapies von Lee, Benjamin J., Liu, Jenny, Griffin, Shawn P., Doh, Jean, Ciurea, Stefan O., Kongtim, Piyanuch, Brem, Elizabeth A.

Volltext

CNS prophylaxis is (mostly) futile in DLBCL von Shieh, Kevin, Brem, Elizabeth

Volltext

BOK: Oddball of the BCL-2 Family von Brem, Elizabeth A, Letai, Anthony

Volltext

Frontline Management of CLL in 2021 von Brem, Elizabeth A, O'Brien, Susan

Volltext

Considerations for the Treatment of Diffuse Large B Cell Lymphoma in the Elderly von Khan, Yasir, Brem, Elizabeth A.

Volltext

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outc... von Wagner, Charlotte B., Boucher, Ken, Nedved, Adrienne, Micallef, Ivana N., Desai, Sanjal, Hatic, Haris, Goyal, Gaurav, Zacholski, Erin, Fegley, Amanda, Sigmund, Audrey M., Bond, David A., Samuels, Courtney, Kamdar, Manali K., Ba Aqeel, Sheeba, Torka, Pallawi, MacDougall, Kira, Borogovac, Azra, Rajeeve, Sridevi, Sundaram, Suchitra, Fedak, Kalub, Modi, Dipenkumar, Travers, Elizabeth, Ayyappan, Sabarish, Chilakamarri, Nitin, Brem, Elizabeth A., Ermann, Daniel A., Fitzgerald, Lindsey A., Hu, Boyu, Stephens, Deborah M., Shah, Harsh

Volltext

Is a BTKi or BCL2i preferable for first “novel” therapy in CLL? The case for BTKis von Brem, Elizabeth A., O'Brien, Susan

Volltext

Treatment Modalities and Survival Outcomes for Sinonasal Diffuse Large B‐Cell Lymphoma von Lehrich, Brandon M., Abiri, Arash, Goshtasbi, Khodayar, Birkenbeuel, Jack, Yasaka, Tyler M., Papagiannopoulos, Peter, Tajudeen, Bobby A., Brem, Elizabeth A., Kuan, Edward C.

Volltext

Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas von Koch, Raphael, Christie, Amanda L., Crombie, Jennifer L., Palmer, Adam C., Plana, Deborah, Shigemori, Kay, Morrow, Sara N., Van Scoyk, Alexandria, Wu, Wenchao, Brem, Elizabeth A., Secrist, J. Paul, Drew, Lisa, Schuller, Alwin G., Cidado, Justin, Letai, Anthony, Weinstock, David M.

Volltext

Anakinra versus etoposide‐based therapy added to high‐dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosis von Lee, Benjamin J., Cao, Yen, Vittayawacharin, Pongthep, É'Leima, Ghaydá, Rezk, Sherif, Reid, Jack, Brem, Elizabeth A., Ciurea, Stefan O., Kongtim, Piyanuch

Volltext

Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologi... von Othman, Tamer, Quan, Michelle A., Zhang, Shiliang, Gaut, Daria, Young, Patricia A., Mahmood, Omar, Abdulhaq, Haifaa, Shieh, Kevin, Reid, Jack, Brem, Elizabeth A, Hariharan, Nisha, Heyman, Benjamin, Tuscano, Joseph

Volltext

Sinonasal lymphoma: A primer for otolaryngologists von Bitner, Benjamin F., Htun, Nyein Nyein, Wang, Beverly Y., Brem, Elizabeth A., Kuan, Edward C.

Volltext

R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis von Othman, Tamer, Penaloza, Juan, Zhang, Shiliang, Daniel, Claire E., Gaut, Daria, Oliai, Caspian, Brem, Elizabeth A, Baweja, Abinav, Ly, Jane, Reid, Jack, Pinter-Brown, Lauren, Lee, Matthew, Abdulhaq, Haifaa, Tuscano, Joseph

Volltext

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study von Haverkos, Bradley, Alpdogan, Onder, Baiocchi, Robert, Brammer, Jonathan E., Feldman, Tatyana A., Capra, Marcelo, Brem, Elizabeth A., Nair, Santosh, Scheinberg, Phillip, Pereira, Juliana, Shune, Leyla, Joffe, Erel, Young, Patricia, Spruill, Susan, Katkov, Afton, McRae, Robert, Royston, Ivor, Faller, Douglas V., Rojkjaer, Lisa, Porcu, Pierluigi

Volltext

SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin... von Brem, Elizabeth A., Li, Hongli, Beaven, Anne W., Caimi, Paolo F., Cerchietti, Leandro, Alizadeh, Ash A., Olin, Rebecca, Henry, N. Lynn, Dillon, Hildy, Little, Richard F., Laubach, Cara, LeBlanc, Michael, Friedberg, Jonathan W., Smith, Sonali M.

Volltext

The Acute Hemolytic Anemias: The Importance of Emergency Diagnosis and Management von Robertson, Jennifer J., MD, MSEd, Brem, Elizabeth, MD, Koyfman, Alex, MD

Volltext

Eponyms in medical oncology von Kumar, Priyanka, Brazel, Danielle, Benjamin, David J., Brem, Elizabeth

Volltext

Eponyms in Malignant Hematology von Brazel, Danielle, Kumar, Priyanka, Benjamin, David J., Brem, Elizabeth

Volltext

Distinct cellular and therapeutic effects of obatoclax in rituximab‐sensitive and ‐resistant lymphomas von Brem, Elizabeth A., Thudium, Karen, Khubchandani, Sapna, Tsai, Ping‐Chiao, Olejniczak, Scott H., Bhat, Seema, Riaz, Wasif, Gu, Jenny, Iqbal, Arshad, Campagna, Ryan, Knight, Joy, Mavis, Cory, Hoskin, Paul, Deeb, George, Gibbs, John F., Fetterly, Gerald, Czuczman, Myron S., Hernandez‐Ilizaliturri, Francisco J.

Volltext